Cargando…

Effects of rebamipide for chronic atrophic gastritis: A protocol for systematic review and meta-analysis

BACKGROUND: Chronic atrophic gastritis (CAG) is defined as an important precancerous disease with high risk of gastric cancer. Rebamipide is a mucosal protective agent widely used in the treatment of chronic gastritis. The aim of this systematic review is to assess the efficacy and safety of rebamip...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Daorui, Yang, Maoyi, Hu, Zhipeng, Yang, Liangjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310858/
https://www.ncbi.nlm.nih.gov/pubmed/32569191
http://dx.doi.org/10.1097/MD.0000000000020620

Ejemplares similares